胰岛素自动输送的早期阶段。

IF 6.3 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes technology & therapeutics Pub Date : 2025-07-01 DOI:10.1089/dia.2025.18802.hz

Howard Zisser, Roman Hovorka, Ananda Basu, Tadej Battelino, Charlotte K Boughton, Marc D Breton, Bruce A Buckingham, Sue A Brown, Daniel R Cherñavvsky, Eyal Dassau, Mark D DeBoer, Francis J Doyle, Laya Ekhlaspour, Chiara Fabris, Gregory P Forlenza, Ahmad Haidar, David C Klonoff, Boris Kovatchev, Aaron J Kowalski, Carol J Levy, Yogish C Kudva, David M Maahs, Moshe Phillip, Eric Renard, Steven J Russell, Viral N Shah, Garry M Steil, R Paul Wadwa, Stuart A Weinzimer

{"title":"胰岛素自动输送的早期阶段。","authors":"Howard Zisser, Roman Hovorka, Ananda Basu, Tadej Battelino, Charlotte K Boughton, Marc D Breton, Bruce A Buckingham, Sue A Brown, Daniel R Cherñavvsky, Eyal Dassau, Mark D DeBoer, Francis J Doyle, Laya Ekhlaspour, Chiara Fabris, Gregory P Forlenza, Ahmad Haidar, David C Klonoff, Boris Kovatchev, Aaron J Kowalski, Carol J Levy, Yogish C Kudva, David M Maahs, Moshe Phillip, Eric Renard, Steven J Russell, Viral N Shah, Garry M Steil, R Paul Wadwa, Stuart A Weinzimer","doi":"10.1089/dia.2025.18802.hz","DOIUrl":null,"url":null,"abstract":"The development of automated insulin delivery systems has seen tremendous improvements from individual components to interoperable system combinations of devices and new drugs besides insulin. The components have become progressively smaller, more accurate, and more user friendly. This article summarizes the history of the artificial pancreas from the earliest concepts to fully functional systems to research into further improvements in the future. The authors include many of the developers of this technology who received research support from the National Institute of Diabetes and Digestive and Kidney Diseases at various stages to develop these systems.","PeriodicalId":11159,"journal":{"name":"Diabetes technology & therapeutics","volume":"27 S3","pages":"S33-S47"},"PeriodicalIF":6.3000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Early Stages of Automated Insulin Delivery.\",\"authors\":\"Howard Zisser, Roman Hovorka, Ananda Basu, Tadej Battelino, Charlotte K Boughton, Marc D Breton, Bruce A Buckingham, Sue A Brown, Daniel R Cherñavvsky, Eyal Dassau, Mark D DeBoer, Francis J Doyle, Laya Ekhlaspour, Chiara Fabris, Gregory P Forlenza, Ahmad Haidar, David C Klonoff, Boris Kovatchev, Aaron J Kowalski, Carol J Levy, Yogish C Kudva, David M Maahs, Moshe Phillip, Eric Renard, Steven J Russell, Viral N Shah, Garry M Steil, R Paul Wadwa, Stuart A Weinzimer\",\"doi\":\"10.1089/dia.2025.18802.hz\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The development of automated insulin delivery systems has seen tremendous improvements from individual components to interoperable system combinations of devices and new drugs besides insulin. The components have become progressively smaller, more accurate, and more user friendly. This article summarizes the history of the artificial pancreas from the earliest concepts to fully functional systems to research into further improvements in the future. The authors include many of the developers of this technology who received research support from the National Institute of Diabetes and Digestive and Kidney Diseases at various stages to develop these systems.\",\"PeriodicalId\":11159,\"journal\":{\"name\":\"Diabetes technology & therapeutics\",\"volume\":\"27 S3\",\"pages\":\"S33-S47\"},\"PeriodicalIF\":6.3000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes technology & therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/dia.2025.18802.hz\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes technology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/dia.2025.18802.hz","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

自动化胰岛素输送系统的发展已经取得了巨大的进步，从单个组件到可互操作的系统组合设备和除胰岛素外的新药。组件逐渐变得更小、更精确、更用户友好。本文综述了人工胰腺的发展历史，从最早的概念到功能齐全的系统，再到未来进一步改进的研究。作者包括该技术的许多开发人员，他们在开发这些系统的各个阶段得到了国家糖尿病、消化和肾脏疾病研究所的研究支持。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Early Stages of Automated Insulin Delivery.

The development of automated insulin delivery systems has seen tremendous improvements from individual components to interoperable system combinations of devices and new drugs besides insulin. The components have become progressively smaller, more accurate, and more user friendly. This article summarizes the history of the artificial pancreas from the earliest concepts to fully functional systems to research into further improvements in the future. The authors include many of the developers of this technology who received research support from the National Institute of Diabetes and Digestive and Kidney Diseases at various stages to develop these systems.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Diabetes technology & therapeutics 医学-内分泌学与代谢

CiteScore

10.60

自引率

14.80%

发文量

145

审稿时长

3-8 weeks

期刊介绍： Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.